Dudediligence.

Lisata Therapeutics, Inc

LSTANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$1.0MDec ’24$70,000Jun ’25$0.00Sep ’25$100,000Dec ’25$0.00Mar ’26$0.00Jun ’26
Net income, by quarter
−$4.9MSep ’24−$4.6MDec ’24−$4.7MMar ’25−$4.7MJun ’25−$4.2MSep ’25−$3.0MDec ’25−$4.5MMar ’26−$2.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on file$0.00$0.00$1.0M$170,000
Operating income−$29.1M−$57.6M−$25.7M−$22.4M−$18.2M
Net income−$27.5M−$54.2M−$20.8M−$20.0M−$16.6M
Operating cash flow−$22.2M−$21.2M−$20.0M−$19.4M−$15.9M
Free cash flow−$22.3M−$21.5M−$20.0M−$19.4M−$16.0M
Cash$24.6M$32.2M$22.6M$16.2M$16.0M
Shares outstanding4.0M7.9M8.1M8.4M8.8M